Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 110 results.

Thumbnail for BTK Inhibitors Are Associated With Significantly Lower Hospitalization and Reduced Cardiovascular Morbidity Compared With Venetoclax-Based Regimens in CLL/SLL: A Propensity Score-Matched, Real-World Analysis

CLL - 693

BTK Inhibitors Are Associated With Significantly Lower Hospitalization and Reduced Cardiovascular Morbidity Compared With Venetoclax-Based Regimens in CLL/SLL: A Propensity Score-Matched, Real-World Analysis

Ekow Pinkrah

Poster Presenter: Ekow Pinkrah

Thumbnail for Risk of Tumor Lysis Syndrome (TLS) Among Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) Treated With Venetoclax: A Real-World Study

CLL - 737

Risk of Tumor Lysis Syndrome (TLS) Among Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) Treated With Venetoclax: A Real-World Study

Alessandra Ferrajoli

Poster Presenter: Alessandra Ferrajoli

Thumbnail for Pirtobrutinib's Cardiac Adverse Reactions: An Early Pharmacovigilance Study

CLL - 763

Pirtobrutinib's Cardiac Adverse Reactions: An Early Pharmacovigilance Study

Maroun Ibrahim

Poster Presenter: Maroun Ibrahim

Thumbnail for Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

CLL - 787

Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

Ahmed Qaedi

Poster Presenter: Ahmed Qaedi

Thumbnail for Pirtobrutinib in Treatment-Naοve (TN) Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Pooled Results From BRUIN CLL-313 and BRUIN CLL-314

CLL - 796

Pirtobrutinib in Treatment-Naοve (TN) Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Pooled Results From BRUIN CLL-313 and BRUIN CLL-314

William G Wierda

Poster Presenter: William G Wierda

Thumbnail for Venetoclax Initiation, Monitoring, and Interventions After Acalabrutinib Lead-In for Chronic Lymphocytic Leukemia

CLL - 823

Venetoclax Initiation, Monitoring, and Interventions After Acalabrutinib Lead-In for Chronic Lymphocytic Leukemia

Emily Lee

Poster Presenter: Emily Lee

Thumbnail for Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis

CLL - 860

Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis

Alexander Mays

Poster Presenter: Alexander Mays

Thumbnail for Infections in Chronic Lymphocytic Leukemia: A National Inpatient Sample Analysis of Prevalence and Mortality

CLL - 864

Infections in Chronic Lymphocytic Leukemia: A National Inpatient Sample Analysis of Prevalence and Mortality

Rabia Iqbal

Poster Presenter: Rabia Iqbal

Thumbnail for Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

CLL - 868

Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.